Deals

AstraZeneca to Invest USD 2 Billion in Summit Therapeutics – Clinical Collaboration Anchored on Ivonescimab and Claudin 18.2 ADC Sone‑Ve
AstraZenecaNASDAQ: SMMT

AstraZeneca to Invest USD 2 Billion in Summit Therapeutics – Clinical Collaboration Anchored on Ivonescimab and Claudin 18.2 ADC Sone‑Ve

Summit Therapeutics Inc. (NASDAQ: SMMT) announced an agreement with AstraZeneca plc (NYSE: AZN) under which AstraZeneca will make an equity investment of USD 2 billion in convertible preferred shares in…

Novo Nordisk Licenses Hengrui's HRS‑1596 in Up to USD 2.6 Billion Global Deal – Once‑Weekly Oral Candidate for Obesity and Type 2 Diabetes

Novo Nordisk Licenses Hengrui’s HRS‑1596 in Up to USD 2.6 Billion Global Deal – Once‑Weekly Oral Candidate for Obesity and Type 2 Diabetes

Novo Nordisk Licenses Nanexa's PharmaShell Platform in Up to EUR 1.165 Billion Global Deal – Targeting Monthly and Quarterly Long‑Acting Injectables for Obesity and Type 2 Diabetes

Novo Nordisk Licenses Nanexa’s PharmaShell Platform in Up to EUR 1.165 Billion Global Deal – Targeting Monthly and Quarterly Long‑Acting Injectables for Obesity and Type 2 Diabetes

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs
LexenpharmSHA: 688621

Lexenpharm and Sun-Novo Partner on Long-Acting Asthma and COPD Drugs

Baheal Pharmaceutical Gains Exclusive Rights to Roche's MabThera in China
Baheal PharmaceuticalCancer

Baheal Pharmaceutical Gains Exclusive Rights to Roche’s MabThera in China

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America
CancerCStone Pharmaceuticals

CStone Pharmaceuticals and SteinCares Ink Licensing Deal for PD-L1 Inhibitor in Latin America

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206
Auto-immuneBio-Thera Solutions

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206

Show More